FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Laurent Bardin

Research Profile

Concepts & Ideas

Living Beings

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Agnès Auclair; Laurent Bardin; Didier Cussac; Peter Heusler; M Marien; J C Martel; A Newman-Tancredi; J A O'Connor; Marie-Bernadette Assié; Ronan Depoortère
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety.
Ronan Depoortère; Mathieu Meleine; Emilie Muller; Monique Aliaga; Denis Ardid; Laurent Bardin; Adrian Newman-Tancredi
Milnacipran is active in models of irritable bowel syndrome and abdominal visceral pain in rodents.
Juan Mico; Adrian Newman-Tancredi; Olivier Vitton; Laurent Bardin; Esther Berrocoso; Philippe Ladure; Ronan Depoortère
Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Laurent Bardin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Agnès Auclair; Laurent Bardin; Didier Cussac; Peter Heusler; M Marien; J C Martel; A Newman-Tancredi; J A O'Connor; Marie-Bernadette Assié; Ronan Depoortère
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety.
Neuropharmacology 2013;70():338-47.
2011: Ronan Depoortère; Mathieu Meleine; Emilie Muller; Monique Aliaga; Denis Ardid; Laurent Bardin; Adrian Newman-Tancredi
Milnacipran is active in models of irritable bowel syndrome and abdominal visceral pain in rodents.
European journal of pharmacology 2011;672(1-3):83-7.
2011: Juan Mico; Adrian Newman-Tancredi; Olivier Vitton; Laurent Bardin; Esther Berrocoso; Philippe Ladure; Ronan Depoortère
Effects of milnacipran, duloxetine and indomethacin, in polyarthritic rats using the Randall-Selitto model.
Behavioural pharmacology 2011;22(5-6):599-606.
2011: Laurent Bardin
The complex role of serotonin and 5-HT receptors in chronic pain.
Behavioural pharmacology 2011;22(5-6):390-404.
2010: Laurent Bardin; S Gregoire; M Aliaga; N Malfetes; O Vitton; P Ladure; Adrian Newman-Tancredi; Ronan Depoortère
Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats.
Neuroscience research 2010;66(2):135-40.
2009: Laurent Bardin; N Malfetes; Adrian Newman-Tancredi; Ronan Depoortère
Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: Relevance to human stress-associated painful pathologies.
Behavioural brain research 2009;205(2):360-6.
2009: Jean-Claude Martel; Marie-Bernadette Assié; Laurent Bardin; Ronan Depoortère; Didier Cussac; Adrian Newman-Tancredi
5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception.
British journal of pharmacology 2009;158(1):232-42.
2009: Ronan Depoortère; Laurent Bardin; Michael Rodrigues; Erika Abrial; Monique Aliaga; Adrian Newman-Tancredi
Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Behavioural pharmacology 2009;20(4):303-11.
2008: Ronan Depoortère; Catherine Barret-Grévoz; Laurent Bardin; Adrian Newman-Tancredi
Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.
European journal of pharmacology 2008;597(1-3):34-8.
2007: Marie-Bernadette Assié; Laurent Bardin; Agnès Auclair; Nathalie Consul-Denjean; François Sautel; Ronan Depoortère; Adrian Newman-Tancredi
F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice.
Naunyn-Schmiedeberg's archives of pharmacology 2007;375(4):241-50.
2007: Ronan Depoortère; Laurent Bardin; Agnès Auclair; Mark S Kleven; Eric P M Prinssen; Francis Colpaert; Bernard Vacher; Adrian Newman-Tancredi
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
British journal of pharmacology 2007;151(2):253-65.
2007: Ronan Depoortère; Agnès Auclair; Laurent Bardin; Liesbeth A Bruins Slot; Mark S Kleven; Francis Colpaert; Bernard Vacher; Adrian Newman-Tancredi
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
British journal of pharmacology 2007;151(2):266-77.
2007: Laurent Bardin; Agnès Auclair; Mark S Kleven; Eric P M Prinssen; Wouter Koek; Adrian Newman-Tancredi; Ronan Depoortère
Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
Behavioural pharmacology 2007;18(2):103-18.
2006: Laurent Bardin; Mark S Kleven; Catherine Barret-Grévoz; Ronan Depoortère; Adrian Newman-Tancredi
Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1869-79.
2005: Ivan Kiss; Anne-Dominique Degryse; Laurent Bardin; Ignacio Alvarez Gomez de Segura; Francis C Colpaert
The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.
European journal of pharmacology 2005;523(1-3):29-39.
2005: Laurent Bardin; Marie-Bernadette Assié; Martine Pélissou; Isabelle Royer-Urios; Adrian Newman-Tancredi; Jean-Paul Ribet; François Sautel; Wouter Koek; Francis C Colpaert
Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1034-42.
2004: Laurent Bardin; Francis C Colpaert
Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.
European journal of pain (London, England) 2004;8(3):253-61.
2003: Laurent Bardin; Jean-Pierre Tarayre; N Malfetes; Wouter Koek; Francis C Colpaert
Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain.
Pharmacology 2003;67(4):182-94.
2002: Francis C Colpaert; Jean-Pierre Tarayre; Wouter Koek; Petrus J Pauwels; Laurent Bardin; X-J Xu; Z Wiesenfeld-Hallin; Cristina Cosi; Elisabeth Carilla-Durand; Marie-Bernadette Assié; Bernard Vacher
Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
Neuropharmacology 2002;43(6):945-58.
2001: Laurent Bardin; Jean-Pierre Tarayre; Wouter Koek; Francis C Colpaert
In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia.
European journal of pharmacology 2001;421(2):109-14.